ClearNote Health’s Avantect® Test Selected for World’s Largest Study of Pancreatic Cancer Detection in High-Risk Patient Population

ClearNote’s Avantect Pancreatic Cancer test was selected for a large UK NHS study that will include up to 15,000 patient participants recently diagnosed with type 2 diabetes. The Avantect test is a blood-based assay designed to use key epigenomic and genomic signals to detect the earliest indicators of pancreatic cancer.

eClinical Solutions Collaborates with Snowflake to Streamline Data for Life Sciences

Integration between eClinical’s elluminate Clinical Data Cloud and Snowflake offers modern data architecture to power clinical data science and AI, unlock data value for healthcare outcomes

Intelliguard Strengthens Leadership and Launches Client Excellence Organization to Drive Growth and Customer Success

- Intelliguard, a leading provider of medication, inventory management and data-intelligence solutions, today announced the appointment of Giovanni Sapio as Chief Financial Officer, along with several other key executive leadership changes. These strategic moves mark a significant milestone in Intelliguard's growth journey, coinciding with the launch of its Client Excellence Organization, designed to further elevate client satisfaction and operational efficiency.

Oxford Nanopore, Action for ME, and University of Edinburgh launch groundbreaking study into the genetics of ME

Oxford Nanopore Technologies will participate in a groundbreaking study will analyse the entire genetic code of up to 17,000 people with Myalgic Encephalomyelitis (ME) in a bid to uncover the genetic causes of the illness.

Concinnity Genetics raises £3m to establish unique RNA-based control systems for precise control of gene therapies in oversubscribed round

Concinnity Genetics, an Edinburgh-based gene control company, is thrilled to announce the closure of its oversubscribed £3m seed funding round. The investment was led by Eos Advisory with support from Scottish Enterprise, Old College Capital (OCC) – the University of Edinburgh’s in-house venture investment fund, and Maven Capital Partners.

BC Platforms-Nottingham Partnership to Power World-Leading University and Hospital Data-Sharing and Research

BC Platforms, a global leader in real-world data, healthcare data management, and analytics, has announced an extended, joint partnership with the University of Nottingham (UoN) and Nottingham University Hospitals NHS Trust (NUH) to provide data-sharing platforms and tools facilitating data sharing, security, and advanced analyses including Trusted Research Environments (TREs*). The outputs of analysing such data, from both clinical and basic research, have the potential to transform our understanding of important healthcare trends, as well as studying devastating diseases such as cancer and diabetes up to the population level. They could also potentially help unlock innovative new solutions and therapies for patients everywhere.

Coronado Research announce appointment of Dr Jennifer Bradford as VP, Head of Data Science

Coronado Research announced today that Dr Jennifer Bradford has been appointed as VP, Head of Data Science.

VieCure’s Halo Intelligence Platform Adopted by Commonwealth Cancer Center

VieCure announced Commonwealth Cancer Center will deploy its Halo Intelligence platform - the first AI-enabled community oncology care solution. Clinicians will use the platform to manage precision oncology data and help determine the optimal personalized treatment path for patients across rural Kentucky.

UC Health Boosts Frontline Workforce Enablement with Technology from Laudio

The Institute of Tissue Medicine of the University of Bern Chooses Indica Labs’ HALO AP® to Become the First Public Health Institute in Switzerland to Deploy Digital Pathology for Diagnostics in the Cloud with Amazon Web Services (AWS)

Indica Labs today announces that the Institute of Tissue Medicine and Pathology at the University of Bern has selected HALO AP® for the Institute’s first-in-country digital pathology deployment in the cloud powered by Amazon Web Services, Inc.

Symbiosis Expands Business Development Team with Two Key Commercial Appointments in the US

ZeOmega Named a Major Player in 2024 IDC MarketScape for U.S. Health Plan Prior Authorization Solutions

ZeOmega®, the leading population health management organization, today announced that it was recognized as a Major Player in the IDC MarketScape: U.S. Health Plan Prior Authorization Solutions 2024 Vendor Assessment (doc #US51810824, November 2024) report. ZeOmega believes this distinction reflects its innovative use of AI and other technologies to optimize prior authorization processes and meet interoperability standards, empowering health plans to improve provider satisfaction and member outcomes with faster, more efficient approvals.

evitria Partners with Sapio Sciences to Streamline Antibody Workflow Management and Reporting

Sapio Sciences, the science-aware™ lab informatics platform, today announced that evitria, a leader in antibody expression services, has selected Sapio’s Electronic Lab Notebook (ELN) and Sapio Report Builder to enhance its sample tracking, data capture, and reporting capabilities.

DNAnexus and Panomics Join Forces to Deliver Comprehensive, Interactive Multi-omics Data Solutions for Biopharma Organizations

DNAnexus and Panomics to Deliver Multi-omics Data Solutions for Biopharma

Certis Oncology Solutions Unveils CertisOI Assistant™ - Bringing Chatbot Efficiency to Oncology Research

The first AI-driven assistant of its kind in the preclinical oncology space, CertisOI Assistant enables users to query vast datasets, perform complex computational analyses, and visualize drug efficacy predictions—all through a seamless, natural language interface. With this solution, Certis is redefining how researchers interact with oncology data, promising to accelerate the development of new cancer therapies and the realization of personalized medicine. Highly specialized for oncology research, CertisOI Assistant’s conversational interface and integration with CertisAI, Certis’ proprietary AI/ML platform allow cancer scientists to easily query both public and proprietary tumor model datasets; perform complex ad hoc analyses; convert results into downloadable tables, charts, and graphs for actionable insights, and leverage AI-generated drug response predictions to inform critical research decisions.

Laudio recognized as one of Modern Healthcare’s Best in Business

Phastar Scoops Prestigious 2024 Scrip Award

Phastar, a global specialist biometrics contract research organization (CRO), has won the Best CRO - Specialist Providers category at the 2024 Scrip Awards.

Oxford Nanopore and UK Biobank to create world’s first epigenetic dataset targeting the causes of cancer, dementia, complex disease

Oxford Nanopore Technologies announced a new collaboration with UK Biobank to create the world’s first comprehensive, large-scale epigenetic dataset.

Intelliguard and Codonics Partner to Strengthen Patient Safety

Intelliguard, a provider of medication management and data-intelligence solutions, announces a strategic partnership with Codonics, a global leader in healthcare technology offering cutting-edge solutions for patient safety. This partnership allows Intelliguard’s Mira Care Station customers to leverage the Codonics Safe Label System (SLS) for fast, compliant, and standardized syringe labeling, ensuring a closed-loop medication process in operating rooms.

CB Insights Recognizes Proscia Among Most Promising Digital Health Companies Of 2024

Proscia also ranks as the top vendor in diagnostic digital pathology market landscapes.